Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report released on Wednesday. The brokerage issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Stock Performance

Shares of RKDA stock opened at $3.98 on Wednesday. The stock has a fifty day moving average price of $5.28 and a 200 day moving average price of $4.00. The stock has a market cap of $5.41 million, a PE ratio of -0.93 and a beta of 0.88. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31.

Hedge Funds Weigh In On Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC acquired a new position in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned about 0.90% of Arcadia Biosciences as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 17.73% of the company’s stock.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.